Trade Summary

3 days ago, CAGNONI PABLO J, serving as President, Global Head of R&D at INCYTE CORP (INCY), sold 10,801 shares at $125.56 per share, for a total transaction value of $1,356,173.56. Following this transaction, CAGNONI PABLO J now holds 183,200 shares of INCY.

This sale represents a 5.57% decrease in CAGNONI PABLO J's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, August 20, 2026 at 5:15 PM ET, 1 day after the trade was made.

INCYTE CORP operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.